3179 results for «380»
3179 results
Innovations in stentless coronary intervention: from DCB technologies to bioresorbable scaffolds
11 Dec 2025 – From GulfPCR-GIM 2025
This session delves into the evolving landscape of stentless coronary interventions, focusing on the structural diversity of Drug-Coated Balloons (DCB) and the promising future of bioresorbable scaffolds (BRS). It emphasizes the role of intracoronary imaging, particularly OCT, in optimizing these therapies. Attendees gain a comprehensive understanding...
NIRS-guided PCI: beyond calcium to precision PCI
11 Dec 2025 – From GulfPCR-GIM 2025
This session explores how near-infrared spectroscopy (NIRS) is redefining PCI by revealing what angiography cannot see. By identifying lipid-rich and vulnerable plaques, NIRS helps anticipate procedural risk and refine decision-making before stent implantation. The session shows how plaque composition, rather than calcium alone, can guide lesion...
Renal denervation today and tomorrow
11 Dec 2025 – From GulfPCR-GIM 2025
Renal denervation is re-emerging as a valuable therapeutic option for selected patients with hypertension.
This session explores how current evidence, consensus statements, and guidelines inform patient selection for ultrasound renal denervation, while providing practical insight into how the procedure is performed in daily practice.
Beyond the technical aspects,...
Challenging CTO Interventions - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session addresses the complexities of chronic total occlusion (CTO) interventions with a collection of challenging cases employing advanced techniques. Topics include IVUS-assisted recanalisation, hybrid approaches incorporating 3D wiring, retrograde interventions after antegrade failure, and management of procedural complications such as vessel rupture. The session also...
Abstracts - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session compiles recent clinical abstracts addressing diverse topics in interventional cardiology. Highlights include the HYBRID-CTO approach from a prospective case series, the cardiovascular impact of empagliflozin in type 2 diabetes, off-label use of intravascular lithotripsy for resistant in-stent lesions, and experiences with non-hyperaemic pressure ratios...
Beyond the horizon - Shaping the future of cardiology through meaningful innovation in structural heart and coronary - LIVE Case
11 Dec 2025 – From GulfPCR-GIM 2025
This live case–based session explores how innovation is shaping structural heart and coronary interventions.
A real-time TAVI case in a degenerated aortic valve highlights pre-procedural imaging, sizing strategies, procedural decision-making, and post-procedural care.
The session also reviews ongoing and upcoming Myval THV trials, showing how new technologies impact...
Global momentum of Shockwave intravascular lithotripsy: evidence, experience and evolution
11 Dec 2025 – From GulfPCR-GIM 2025
This session examines the growing global experience in the treatment of calcified coronary lesions, bringing together updated clinical evidence and real-world practice.
Recent data are discussed alongside insights from high-volume operators to show how calcium modification strategies are evolving and being integrated into contemporary PCI workflows.
By combining...
Vascular interventions for the invasive cardiologist
11 Dec 2025 – From GulfPCR-GIM 2025
This session delivers a comprehensive overview of recent guideline changes in peripheral vascular disease and shares expert cardiologist experiences in various vascular interventions through case-based discussions. It also focuses on recognizing and managing peripheral vascular complications effectively to optimize patient outcomes.
Challenging STEMI scenarios - Part 1
11 Dec 2025 – From GulfPCR-GIM 2025
This session addresses challenging STEMI scenarios with a focus on atypical presentations, complex complications, and advanced management strategies. Through diverse case discussions, it highlights approaches to overcome procedural difficulties, manage large thrombus burdens, and avoid clinical pitfalls in acute STEMI care.
Calcified lesions: LIVE Educational Case from King Faisal Cardiac Center, National Guard Health Affairs- Western region - Jeddah, Saudi Arabia
11 Dec 2025 – From GulfPCR-GIM 2025
This educational session from King Faisal Cardiac Center provides a detailed examination of optimal device use in calcified coronary lesions, emphasizing the role of intracoronary imaging to improve PCI results and patient outcomes. It also offers guidance on selecting appropriate strategies for coronary bifurcation lesions through...
Innovation and teamwork in structural heart interventions
11 Dec 2025 – From GulfPCR-GIM 2025
This session explores innovations and collaborative approaches in structural heart interventions, focusing on aortic and mitral valve procedures. It addresses procedural indications, challenges, and the evolving roles of non-physician allied professionals. Interactive elements foster knowledge exchange and support the growth of expertise in the structural heart...
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
Discover the new Evolut™ PRO+ TAVI System
17 Jun 2021
New data from Optimize PRO interim analysis
From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis
12 May 2020
Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)